Preparation of gold nanoparticles by novel bacterial exopolysaccharide for antibiotic delivery

dc.contributor.authorPradeepa, n.
dc.contributor.authorVidya, S.M.
dc.contributor.authorMutalik, S.
dc.contributor.authorBhat, K.U.
dc.contributor.authorHuilgol, P.
dc.contributor.authorAvadhani, K.
dc.date.accessioned2026-02-05T09:33:12Z
dc.date.issued2016
dc.description.abstractAim To develop potent drug delivery agents to treat multidrug resistant (MDR) bacterial infections using gold nanoparticles (AuNPs) prepared by bacterial exopolysaccharide (EPS) being a reducing and stabilizing agent. Methods Gold nanoparticles were prepared by EPS, extracted from Lactobacillus plantarum. AuNPs were characterized by UV-visible spectrophotometer, transmission electron microscope (TEM), zeta potential and Fourier transform infrared spectroscopy. Antibiotics used for functionalization of AuNPs were levofloxacin, cefotaxime, ceftriaxone and ciprofloxacin. The resulted functionalized AuNPs were tested against various MDR bacteria by employing different assays such as well diffusion assay, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time killing assay. Key findings The nanostructures exhibited excellent bactericidal activity and reduced MIC and MBC against MDR Gram positive and Gram negative bacteria compared to free drugs. Escherichia coli was the most susceptible MDR bacteria followed by Klebsiella pneumoniae and Staphylococcus aureus. TEM results revealed that the bactericidal activity of nanostructures could be mediated by penetration, loss of cytoplasmic contents and cell lysis. Significance Antibiotic functionalized nanostructures were more potent than free drugs and could be used as potent drug delivery vehicles. © 2016 Elsevier Inc. All rights reserved.
dc.identifier.citationLife Sciences, 2016, 153, , pp. 171-179
dc.identifier.issn243205
dc.identifier.urihttps://doi.org/10.1016/j.lfs.2016.04.022
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26002
dc.publisherElsevier Inc. usjcs@elsevier.com
dc.subjectantibiotic agent
dc.subjectcefotaxime
dc.subjectceftriaxone
dc.subjectciprofloxacin
dc.subjectexopolysaccharide
dc.subjectgold nanoparticle
dc.subjectlevofloxacin
dc.subjectreducing agent
dc.subjectstabilizing agent
dc.subjectantiinfective agent
dc.subjectgold
dc.subjectmetal nanoparticle
dc.subjectpolysaccharide
dc.subjectantibiotic sensitivity
dc.subjectArticle
dc.subjectbacterial infection
dc.subjectbactericidal activity
dc.subjectcontrolled study
dc.subjectcytolysis
dc.subjectdrug delivery system
dc.subjectEscherichia coli
dc.subjectimmunodiffusion
dc.subjectinfrared spectroscopy
dc.subjectKlebsiella pneumoniae
dc.subjectLactobacillus plantarum
dc.subjectminimum bactericidal concentration
dc.subjectminimum inhibitory concentration
dc.subjectmultidrug resistance
dc.subjectnonhuman
dc.subjectStaphylococcus aureus
dc.subjecttransmission electron microscopy
dc.subjectultraviolet spectrophotometry
dc.subjectzeta potential
dc.subjectchemistry
dc.subjectLactobacillus
dc.subjectAnti-Bacterial Agents
dc.subjectDrug Delivery Systems
dc.subjectGold
dc.subjectMetal Nanoparticles
dc.subjectMicroscopy, Electron, Transmission
dc.subjectPolysaccharides
dc.subjectSpectroscopy, Fourier Transform Infrared
dc.titlePreparation of gold nanoparticles by novel bacterial exopolysaccharide for antibiotic delivery

Files

Collections